Long-Term Debt: The sum of all long term debt fields.
DMK Pharmaceuticals Corporation (DMKPQ) Long-Term Debt data is not available for the most recently reported fiscal year, ending 2022-12-31.
| Income Statement Financials | |
$4.76M |
|
$-26.48M |
|
$6.19M |
|
$-1.43M |
|
$29.82M |
|
$-25.06M |
|
$-1.14M |
|
$-26.20M |
|
$-26.20M |
|
$-26.20M |
|
$-26.20M |
|
$-26.48M |
|
$-26.20M |
|
$-25.06M |
|
$-23.58M |
|
2.14M |
|
2.14M |
|
$-12.59 |
|
$-12.59 |
|
| Balance Sheet Financials | |
$9.27M |
|
$1.29M |
|
$1.66M |
|
$10.93M |
|
$11.40M |
|
|
Long-Term Debt |
-- |
$0.34M |
|
$11.74M |
|
$-0.81M |
|
$-0.81M |
|
$-0.81M |
|
2.14M |
|
| Cash Flow Statement Financials | |
$-25.90M |
|
$3.48M |
|
$0.28M |
|
$23.25M |
|
$1.11M |
|
$-22.14M |
|
$-0.34M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.81 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-30.10% |
|
-526.88% |
|
-526.88% |
|
-495.69% |
|
-550.82% |
|
-556.73% |
|
$-26.58M |
|
-- |
|
-- |
|
-- |
|
0.44 |
|
4.99 |
|
4.38 |
|
83.27 |
|
3242.20% |
|
3242.23% |
|
-239.68% |
|
3242.23% |
|
$-0.38 |
|
$-12.40 |
|
$-12.09 |
|